EUR 0.98
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 29.17 Million EUR | -6.03% |
2022 | 26.07 Million EUR | 9.6% |
2021 | 23.29 Million EUR | 45.45% |
2020 | 15.74 Million EUR | -38.08% |
2019 | 25.42 Million EUR | 37.82% |
2018 | 18.09 Million EUR | 19.91% |
2017 | 15.89 Million EUR | 24.78% |
2016 | 11.34 Million EUR | 33.58% |
2015 | 8.55 Million EUR | 2.51% |
2014 | 8.12 Million EUR | 309.96% |
2013 | 1.75 Million EUR | 5.21% |
2012 | 1.68 Million EUR | 121.62% |
2011 | 874 Thousand EUR | 115.34% |
2010 | 871 Thousand EUR | 12.71% |
2009 | -6.62 Million EUR | -112.07% |
2008 | -4.76 Million EUR | -8.68% |
2007 | -221 Thousand EUR | -8.85% |
2006 | 64.97 Million EUR | -2.44% |
2005 | -4.83 Million EUR | 163.75% |
2004 | -3.69 Million EUR | -28.42% |
2003 | 35.27 Million EUR | -26.6% |
2002 | 48.06 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 5.91 Million EUR | -20.83% |
2024 Q2 | 7.6 Million EUR | 22.9% |
2023 Q4 | 1.32 Million EUR | -71.89% |
2023 FY | - EUR | -6.03% |
2023 Q1 | 6.14 Million EUR | -39.32% |
2023 Q2 | 8.33 Million EUR | 35.53% |
2023 Q3 | 4.71 Million EUR | -43.48% |
2022 Q3 | 4.57 Million EUR | -1.72% |
2022 FY | - EUR | 9.6% |
2022 Q4 | 10.13 Million EUR | 121.61% |
2022 Q1 | 3.92 Million EUR | -38.67% |
2022 Q2 | 4.65 Million EUR | 18.46% |
2021 Q1 | 939 Thousand EUR | -77.98% |
2021 Q3 | 6.86 Million EUR | -2.43% |
2021 Q2 | 7.03 Million EUR | 649.52% |
2021 Q4 | 6.4 Million EUR | -6.73% |
2021 FY | - EUR | 45.45% |
2020 FY | - EUR | -38.08% |
2020 Q4 | 4.26 Million EUR | -28.79% |
2020 Q3 | 5.98 Million EUR | 406.17% |
2020 Q2 | 1.18 Million EUR | -62.73% |
2020 Q1 | 3.17 Million EUR | -55.3% |
2019 Q2 | 4.87 Million EUR | -24.33% |
2019 Q1 | 6.43 Million EUR | 7.48% |
2019 Q4 | 7.1 Million EUR | 36.9% |
2019 Q3 | 5.18 Million EUR | 6.51% |
2019 FY | - EUR | 37.82% |
2018 Q4 | 5.98 Million EUR | 33.48% |
2018 Q2 | 4.23 Million EUR | 75.84% |
2018 Q1 | 2.4 Million EUR | -52.29% |
2018 Q3 | 4.48 Million EUR | 5.9% |
2018 FY | - EUR | 19.91% |
2017 Q1 | 2.42 Million EUR | -61.2% |
2017 FY | - EUR | 24.78% |
2017 Q4 | 5.04 Million EUR | 73.09% |
2017 Q3 | 2.91 Million EUR | -24.88% |
2017 Q2 | 3.88 Million EUR | 59.99% |
2016 FY | - EUR | 33.58% |
2016 Q2 | 2.78 Million EUR | 368.52% |
2016 Q3 | 1.86 Million EUR | -33.06% |
2016 Q4 | 6.25 Million EUR | 235.75% |
2016 Q1 | 594 Thousand EUR | -86.6% |
2015 Q4 | 4.43 Million EUR | 209.78% |
2015 Q3 | 1.43 Million EUR | -39.0% |
2015 Q2 | 2.34 Million EUR | 306.59% |
2015 Q1 | 577 Thousand EUR | -92.81% |
2015 FY | - EUR | 2.51% |
2014 Q3 | 820 Thousand EUR | 2833.33% |
2014 FY | - EUR | 309.96% |
2014 Q1 | -653 Thousand EUR | -129.79% |
2014 Q2 | -30 Thousand EUR | 95.41% |
2014 Q4 | 8.02 Million EUR | 879.15% |
2013 FY | - EUR | 5.21% |
2013 Q1 | -545 Thousand EUR | -122.28% |
2013 Q4 | 2.19 Million EUR | 752.92% |
2013 Q3 | 257 Thousand EUR | 76.03% |
2013 Q2 | 146 Thousand EUR | 126.79% |
2012 Q3 | -144 Thousand EUR | -204.35% |
2012 Q1 | -6000.00 EUR | -100.13% |
2012 Q4 | 2.44 Million EUR | 1798.61% |
2012 FY | - EUR | 121.62% |
2012 Q2 | 138 Thousand EUR | 2400.0% |
2011 Q2 | -2.37 Million EUR | 12.05% |
2011 Q1 | -2.69 Million EUR | -268.39% |
2011 Q3 | -2000.00 EUR | 99.92% |
2011 Q4 | 4.78 Million EUR | 239150.0% |
2011 FY | - EUR | 115.34% |
2010 Q4 | 1.6 Million EUR | 223.82% |
2010 FY | - EUR | 12.71% |
2010 Q1 | -3.13 Million EUR | -175.77% |
2010 Q2 | -2.87 Million EUR | 8.08% |
2010 Q3 | -1.29 Million EUR | 55.06% |
2009 FY | - EUR | -112.07% |
2009 Q4 | 4.13 Million EUR | 755.71% |
2009 Q3 | -630 Thousand EUR | 0.0% |
2008 FY | - EUR | -8.68% |
2007 FY | - EUR | -8.85% |
2006 FY | - EUR | -2.44% |
2005 FY | - EUR | 163.75% |
2004 FY | - EUR | -28.42% |
2003 FY | - EUR | -26.6% |
2002 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Miliboo Société anonyme | 3.13 Million EUR | -831.056% |
Neolife SA | 133.43 Thousand EUR | -21760.503% |
U10 Corp | 2.91 Million EUR | -900.343% |
Roche Bobois S.A. | 92.84 Million EUR | 68.581% |
SEB SA | 913.6 Million EUR | 96.807% |